Cargando…
Potent and Targeted Sindbis Virus Platform for Immunotherapy of Ovarian Cancer
Our laboratory has been developing a Sindbis viral (SV) vector platform for treatments of ovarian and other types of cancers. In this study we show that SV.IL-12 combined with an agonistic OX40 antibody can eliminate ovarian cancer in a Mouse Ovarian Surface Epithelial Cell Line (MOSEC) model and fu...
Autores principales: | Opp, Silvana, Hurtado, Alicia, Pampeno, Christine, Lin, Ziyan, Meruelo, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818975/ https://www.ncbi.nlm.nih.gov/pubmed/36611875 http://dx.doi.org/10.3390/cells12010077 |
Ejemplares similares
-
Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy
por: Pampeno, Christine, et al.
Publicado: (2023) -
Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors
por: Scherwitzl, Iris, et al.
Publicado: (2020) -
Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
por: Scaglione, Antonella, et al.
Publicado: (2021) -
Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity.
por: Scaglione, Antonella, et al.
Publicado: (2021) -
Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity
por: Scherwitzl, Iris, et al.
Publicado: (2018)